K. Tanaka et al. / European Journal of Pharmaceutical Sciences 13 (2001) 77–83
79
1
1
which were sublimed at 808C. H NMR (DMSO-d6 ): d
127.5–128.08C. H NMR (CDCl3): d 2.21 (ddd, 1H, J5
13.8, 11.0, 6.3 Hz), 2.40 (s, 3H), 2.44 (s, 3H), 2.53 (ddd,
1H, J513.9, 5.1, 0.6 Hz), 4.51 (ddd, 1H, J54.0, 4.0, 2.0
Hz), 4.63 (dd, 1H, J511.8, 3.8 Hz), 4.66 (dd, 1H, J512.0,
4.0 Hz), 5.15 (s, 2H), 5.22 (dd, 1H, J510.5, 5.0 Hz), 5.59
(dd, 1H, J55.3, 1.3 Hz), 6.96 (d, 1H, J58.5 Hz), 7.21 (d,
2H, J57.5 Hz), 7.24–7.29 (m, overlapped with residual
CHCl3) 7.35–7.43 (m, 5H), 7.94 (d, 2H, J58.5 Hz), 7.98
(d, 2H, J58.0 Hz), 8.36 (d, 1H, J52.0 Hz), 8.61 (br, 1H,
D2O exchangeable). 13C NMR (CDCl3): d 21.7, 21.7,
41.6, 65.0, 71.4, 77.1, 80.3, 83.0, 112.4, 115.6 (q, JC–F5
288 Hz, CF3), 118.4, 123.2, 125.3, 126.9, 127.1, 127.3,
128.6, 128.9, 129.1, 129.2, 129.8, 134.1, 135.7, 143.7,
144.1, 147.1, 154.3 (q, J2C–F537.2 Hz, CO), 166.1, 166.4.
FAB mass (positive): m/z, proposed ion: 648, [M1H]1.
a-anomer 7: colorless solid, mp 127.0–128.58C. 1H NMR
(CDCl3): d 2.29 (ddd, 1H, J513.7, 6.4, 4.2 Hz), 2.39 (s,
3H), 2.41 (s, 3H), 2.95 (ddd, 1H, J514.0, 7.0, 7.0 Hz),
4.54 (dd, 1H, J511.8, 4.4 Hz), 4.58 (dd, 1H, J511.7, 4.9
Hz), 4.70 (br, 1H), 5.16 (s, 2H), 5.31 (dd, 1H, J56.8, 6.8
Hz), 5.59 (ddd, 1H, J56.9, 4.0, 3.1 Hz), 6.68 (d, 1H,
J58.5 Hz), 7.17 (d, 2H, J57.9 Hz), 7.22–7.25 (m, 3H),
7.35–7.43 (m, 5H), 7.79 (d, 2H, J58.1 Hz), 7.96 (d, 2H,
J58.1 Hz), 8.42 (d, 1H, J52.2 Hz), 8.62 (br, 1H, D2O
exchangeable).
6.83 (ddd, 1H, J57.6, 7.6, 1.4 Hz), 6.94 (dd, 1H, J58.1,
1.2 Hz), 7.14 (ddd, 1H, J58.1, 7.5, 1.6 Hz), 7.32 (dd, 1H,
J57.8, 1.5 Hz), 9.97 (br, 1H, D2O exchangeable), 10.42
(br, 1H, D2O exchangeable). 13C NMR (DMSO-d6 ): d
116.0 (q, JC–F5288 Hz, CF3), 116.0, 118.9, 122.1, 126.3,
127.9, 151.2, 154.9 (q, J2C–F536.2 Hz, CO). LRMS (70 eV,
EI) m/z (relative intensity, proposed ion): 205 (71.4, M1),
136 (100.0, M1–CF3), 108 (50.4, M1–CF3CO).
2.3. O-Benzyl-2-trifluoroacetamidephenol (5)
To a solution of 2-trifluoroacetamidephenol 4 (47.7 g,
233 mmol) and iPr2EtN (60 ml, 350 mmol) in dry 1,2-
dichloroethane (470 ml) was added benzyl chloride (40
ml, 348 mmol) at room temperature. The reaction mixture
was stirred for 30 min at 558C, and then heated at reflux
for 15.5 h. After cooling down to room temperature,
iPr2EtN (60 ml) and benzyl chloride (40 ml) were added
to the solution. After refluxing for 4 h, the solution was
poured into a 2% HCl aqueous solution (1.23 l). The
organic layer was separated, and then the aqueous layer
was extracted with CH2Cl2. The organic layer was washed
with brine, and then the aqueous layer separated was
further extracted with two portions of CH2Cl2. The
combined organic extracts were dried over anhydrous
MgSO4 and the solvent was concentrated. The residue was
purified by silica gel column chromatography (9f324 cm)
with AcOEt-n-hexane (3:97), followed by recrystallization
from n-hexane to afford 33.9 g (49%) of 5 as colorless
2.5. O-Benzyl-2-trifluoroacetamide-4-(1,2-dideoxy-b-D-
ribofuranos-1-yl)-phenol (8)
To a solution of 6 (2.00 g, 3.09 mmol) in dry MeOH (47
ml) was added in one portion a solution of 28% MeONa in
MeOH (1.65 ml, 8.55 mmol) at room temperature. The
reaction mixture was stirred for 2.2 h at room temperature.
After adding Dowex 50W38 (pyridinium form) (31.7 g),
the mixture was further stirred for 2 min. After removing
the resin, the filtrates were combined and then concen-
trated. The resulting oil was purified by silica gel column
chromatography (3f310.5 cm) with MeOH–CH2Cl2
(5:95) to afford 1.21 g (95%) of 8 as colorless solid, mp
1
needles, mp 76.0–76.58C. H NMR (CDCl3): d 5.17 (s,
2H), 7.01 (dd, 1H, J58.3, 1.5 Hz), 7.03 (ddd, 1H, J57.8,
7.8, 1.5 Hz), 7.15 (ddd, 1H, J57.9, 7.9, 1.7 Hz), 7.36–7.43
(m, 5H), 8.32 (dd, 1H, J58.3, 1.8 Hz), 8.64 (br, 1H, D2O
exchangeable). 13C NMR (CDCl3): d 71.3, 112.2, 115.7 (q,
J
C–F5288 Hz, CF3), 120.3, 121.7, 125.5, 126.0, 127.3,
128.5, 128.9, 135.8, 147.5, 154.3 (q, J2C–F537.2 Hz, CO).
LRMS (70 eV, EI) m/z (relative intensity, proposed ion):
295 (100.0, M1), 204 (9.7, M1–CH2C6H5), 135 (48.4,
M1–CH2C6H5 –CF3).
1
126.58C. H NMR (CDCl3): d 1.85 (d, 1H, J54.2 Hz,
D2O exchangeable), 1.98 (dd, 1H, J56.2, 6.2 Hz, D2O
exchangeable), 2.06 (ddd, 1H, J513.3, 10.0, 6.2 Hz), 2.26
(ddd, 1H, J513.3, 5.7, 2.1 Hz), 3.77 (ddd, 1H, J511.6,
6.6, 4.9 Hz), 3.86 (ddd, 1H, J511.8, 5.7, 4.2 Hz), 4.02
(ddd, 1H, J54.3, 4.3, 3.1 Hz), 4.47 (ddd, 1H, J58.9, 3.4,
2.7 Hz), 5.16 (dd, 1H, J510.3, 5.9 Hz), 5.17 (s, 2H), 6.97
(d, 1H, J58.3 Hz), 7.14 (dd, 1H, J58.5, 2.2 Hz), 7.37–
7.42 (m, 5H), 8.38 (d, 1H, J52.0 Hz), 8.64 (s, 1H, D2O
exchangeable).
2.4. O-Benzyl-2-trifluoroacetamide-4-(1,2-dideoxy-3,5-O-
ditoluoyl-b-D-ribofuranos-1-yl)-phenol (6)
A solution of 1-O-methyl-3,5-O-ditoluoyl-2-deoxy-D-
ribofuranose (520 mg, 1.35 mmol) and O-benzyl-2-tri-
fluoroacetamidephenol 5 (403 mg, 1.36 mmol) in CH2Cl2
(2 ml) in the presence of SnCl4 (310 ml, 2.65 mmol) was
stirred for 30 min at 08C. The reaction mixture was
quenched by saturated NaHCO3 aqueous solution (10 ml)
and the resulting precipitates were removed through a thin
pad of Celite. The organic filtrate was washed with brine,
dried over anhydrous MgSO4, and then concentrated. The
residue was chromatographed (2.4f314 cm) on silica gel
with AcOEt-n-hexane (1:9) to give 134 mg (15%) of 6 and
13 mg (1.5%) of 7. b-anomer 6: colorless solid, mp
2.6. 2-Amino-4-(1,2-dideoxy-b-D-ribofuranos-1-yl)-
phenol (2)
A solution of 8 (132 mg, 0.321 mmol) in 40% (w/v)
MeNH2 –MeOH (0.64 ml, 8.24 mmol) was stirred for 11 h.